{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:07Z","timestamp":1781647027801,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To expand the clinical features, epilepsy phenotype, and genotype in individuals with AFG2A-related encephalopathy (AFG2A-RE), previously known SPATA5-related encephalopathy, and to explore potential associations between genotype and epilepsy manifestations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic literature review focusing on AFG2A-RE publications (45 patients), also included 6 of our patients recently reported as the result of a multicentre, retrospective, observational, and descriptive study. Available clinical descriptions, electroencephalography and MRI data, metabolic screening, genetic findings, and treatment responses were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 51 individuals with AFG2A-RE were included, 29 males; mean age 8.35\u2009years. The most frequently described clinical features included intellectual disability (97.92%), hearing loss (93.62%), microcephaly (85.71%), visual impairment (79.49%), hypotonia (71.74%), spasticity (60.87%), and movement disorders (36.96%). Epilepsy was present in 74.71% of cases, with seizures of generalized onset being the most common (70.83%), and infantile epileptic spasms syndrome (IESS) was the predominant epilepsy syndrome at onset (66.67%). Epilepsy was often drug-resistant (82.35%). Brain MRI abnormalities were frequently observed (68.29%), including hypomyelination (39.02%), brain atrophy (34.15%), and a thin corpus callosum (29.27%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>This review presents the largest cohort of individuals with AFG2A-RE reported to date. AFG2A-RE is an ultra-rare, recessive disorder, sometimes presenting as a developmental and epileptic encephalopathy (DEE), characterised by the triad of epilepsy, congenital microcephaly, and deafness, and typically associated with intellectual disability, spasticity, and movement disorders. The cardinal clinical features of AFG2A-RE may mimic those of a mitochondrial disease. No significant associations between genotype and epilepsy phenotype were observed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04204-w","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:55:08Z","timestamp":1775217308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AFG2A-related encephalopathy, expanding the neurodevelopmental and epileptic spectrum"],"prefix":"10.1186","volume":"21","author":[{"given":"Laia","family":"Nou-Fontanet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Cantalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia Ram\u00edrez","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica Gonz\u00e1lez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica Delgadillo","family":"Chilavert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Soto","family":"Insuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Arrabal","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Alonso-Colmenero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Arzimanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-1350","authenticated-orcid":false,"given":"Carmen","family":"Fons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"3","key":"4204_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajhg.2015.07.014","volume":"97","author":"AJ Tanaka","year":"2015","unstructured":"Tanaka AJ, Cho MT, Millan F, Juusola J, Retterer K, Joshi C, et al. Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss. The Am J Hum Genet [Internet]. 2015, Sep, 3;97(3):457\u201364. cited 2022 Oct 14","journal-title":"The Am J Hum Genet"},{"issue":"5","key":"4204_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/cge.12813","volume":"90","author":"H Kurata","year":"2016","unstructured":"Kurata H, Terashima H, Nakashima M, Okazaki T, Matsumura W, Ohno K, et al. Characterization ofSPATA5-related encephalopathy in early childhood. Clin Genet. 2016, Jul, 4;90(5):437\u201344","journal-title":"Clin Genet"},{"key":"4204_CR3","doi-asserted-by":"crossref","unstructured":"Buchert R, Nesbitt AI, Tawamie H, Krantz ID, Medne L, Helbig I, et al. SPATA5 mutations cause a distinct autosomal recessive phenotype of intellectual disability, hypotonia and hearing loss. Orphanet J Rare Dis. 2016, Sep, 29;11(1)","DOI":"10.1186\/s13023-016-0509-9"},{"issue":"3","key":"4204_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41431-017-0001-6","volume":"26","author":"S Puusepp","year":"2018","unstructured":"Puusepp S, Kovacs-Nagy R, Alhaddad B, Braunisch M, Hoffmann GF, Kotzaeridou U, et al. Compound heterozygous SPATA5 variants in four families and functional studies of SPATA5 deficiency. Eur J Hum Genet. 2018, Jan, 17;26(3):407\u201319","journal-title":"Eur J Hum Genet"},{"key":"4204_CR5","doi-asserted-by":"crossref","unstructured":"Szcza\u0142uba K, Szyma\u0144ska, Kosi\u0144ska, Pollak A, Murcia V, K\u0119dra, et al. Isolated hearing impairment caused by SPATA5 mutations in a family with variable phenotypic expression. Adv Exp Med Biol. 2017, Jan, 1;980:59\u201366","DOI":"10.1007\/5584_2016_206"},{"issue":"3","key":"4204_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41431-018-0299-8","volume":"27","author":"SM Papuc","year":"2019","unstructured":"Papuc SM, Abela L, Steindl K, Begemann A, Simmons TL, Schmitt B, et al. The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. Eur J Hum Genet. 2019, Mar, 1;27(3):408\u201321","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"4204_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1684\/epd.2020.1204","volume":"22","author":"C Zanus","year":"2020","unstructured":"Zanus C, Costa P, Faletra F, Musante L, Russo A, Grazian L, et al. Description of a peculiar alternating ictal electroclinical pattern in a young boy with a novel SPATA5 mutation. Epileptic Disord. 2020, Oct, 1;22(5):659\u201363","journal-title":"Epileptic Disord"},{"issue":"15","key":"4204_CR8","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.3390\/ijms22157835","volume":"22","author":"F Braun","year":"2021","unstructured":"Braun F, Hentschel A, Sickmann A, Marteau T, Hertel S, F\u00f6rster F, et al. Muscular and Molecular pathology associated with SPATA5 deficiency in a Child with EHLMRS. Int J Mol Sci. 2021, Jul, 22;22(15):7835","journal-title":"Int J Mol Sci"},{"key":"4204_CR9","doi-asserted-by":"crossref","unstructured":"\u0421\u0442\u0430\u043d\u0447\u0435\u0432\u0430 \u041c, \u0422\u043e\u0434\u043e\u0440\u043e\u0432\u0430 \u0410, \u0422\u043e\u0434\u043e\u0440\u043e\u0432 \u0422 \u0438 \u0441\u044a\u0430\u0432\u0442. \u041a\u043b\u0438\u043d\u0438\u0447\u043d\u0430 \u043a\u0430\u0440\u0442\u0438\u043d\u0430 \u0438 \u0433\u0435\u043d\u0435\u0442\u0438\u0447\u043d\u0438 \u043a\u043e\u0440\u0435\u043b\u0430\u0446\u0438\u0438 \u043f\u0440\u0438 \u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u0438 \u0441 \u043c\u0443\u0442\u0430\u0446\u0438\u0438 \u043d\u0430 SPATA 5 \u0433\u0435\u043d. \u0420\u0435\u0434\u043a\u0438 \u0431\u043e\u043b\u0435\u0441\u0442\u0438 \u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430 \u0441\u0438\u0440\u0430\u0446\u0438 2020;11(4): 19-23. (Translation: Stancheva M, Todorova A, Todorov T, et al. Clinical picture and genetic correlations in Bulgarian patients with SPATA 5 gene mutations. Rare Dis Orphan Drugs. 2020;11(4):19\u201323).","DOI":"10.36865\/2020.v11i4.126"},{"issue":"1","key":"4204_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40246-023-00463-x","volume":"17","author":"V Raggio","year":"2023","unstructured":"Raggio V, Gra\u00f1a M, Winiarski E, Mansilla S, Simoes C, Rodr\u00edguez S, et al. Computational and mitochondrial functional studies of novel compound heterozygous variants in SPATA5 gene support a causal link with epileptogenic encephalopathy. Hum Genomics. 2023, Feb, 27;17(1):14\u20134","journal-title":"Hum Genomics"},{"key":"4204_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejpn.2025.07.007","volume":"58","author":"L Nou-Fontanet","year":"2025","unstructured":"Nou-Fontanet L, Musokhranova U, Camacho AR, Chilavert VD, Insuga VS, Fern\u00e1ndez LA, et al. AFG2A-related encephalopathy: effectiveness of ketogenic diet in epilepsy and mitochondrial dynamics modulation. Eur J Paediatric Neurol. 2025, Sep;58:20\u201326","journal-title":"Eur J Paediatric Neurol"},{"issue":"13","key":"4204_CR12","doi-asserted-by":"publisher","first-page":"110597","DOI":"10.1016\/j.celrep.2022.110597","volume":"38","author":"C Ni","year":"2022","unstructured":"Ni C, Schmitz DA, Lee J, Paw\u0142owski K, Wu J, Buszczak M. Labeling of heterochronic ribosomes reveals C1ORF109 and SPATA5 control a late step in human ribosome assembly. Cell Rep. 2022, Mar;38(13):110597","journal-title":"Cell Rep"},{"issue":"9","key":"4204_CR13","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.cell.2024.03.002","volume":"187","author":"V Krishnamoorthy","year":"2024","unstructured":"Krishnamoorthy V, Foglizzo M, Dilley RL, Wu A, Datta A, Dutta P, et al. The SPATA5-SPATA5L1 ATPase complex directs replisome proteostasis to ensure genome integrity. Cell. 2024, Mar, 29;187(9):2250\u201368.e31","journal-title":"Cell"},{"key":"4204_CR14","doi-asserted-by":"crossref","unstructured":"Dai Y, Wu D, Li N, Ma C, Zhang Y, Gao N. Cryo-EM structure of the AAA+ SPATA5 complex and its role in human cytoplasmic pre-60S maturation. Nat Commun. 2025, Apr, 23;16(1)","DOI":"10.1038\/s41467-025-58894-0"},{"key":"4204_CR15","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 2021;372(71)","DOI":"10.1186\/s13643-021-01626-4"},{"issue":"5","key":"4204_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for Molecular Pathology. Genet In Med: Off J Am Coll Of Med Genet. 2015;17(5):405\u201324","journal-title":"Genet In Med: Off J Am Coll Of Med Genet"},{"key":"4204_CR17","doi-asserted-by":"crossref","unstructured":"Der V, Tse GT, Ferretti A, Garone G, Post B, Specchio N, et al. Movement disorders in patients with genetic developmental and epileptic encephalopathies. Neurology. 2023, Nov, 7;101(19)","DOI":"10.1212\/WNL.0000000000207808"},{"key":"4204_CR18","doi-asserted-by":"crossref","unstructured":"Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022, May, 3;63(6)","DOI":"10.1111\/epi.17241"},{"issue":"10","key":"4204_CR19","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.ajhg.2021.08.003","volume":"108","author":"EM Richard","year":"2021","unstructured":"Richard EM, Bakhtiari S, Marsh APL, Kaiyrzhanov R, Wagner M, Shetty S, et al. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. The Am J Hum Genet. 2021, Oct, 1;108(10):2006\u201316","journal-title":"The Am J Hum Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04204-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:27:42Z","timestamp":1781645262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04204-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4204"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04204-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local institutional ethics committee (Sant Juan de D\u00e9u Hospital ID number: PIC-131\u201318). All research was conducted in accordance with the principles of the Declaration of Helsinki (2024). Written informed consent to participate was obtained from the parents or legal representatives of all newly described individuals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical data was obtained from the parents or legal representatives of all newly described individuals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CF has served on scientific advisory board for longboard pharmaceuticals and biocodex and has received speaker honoraria from Nutricia, UCB, and Jazz Pharmaceuticals. The authors declare that there are no other conflicts of interest relevant to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}